Ipamorelin 10mg/vial – US Stock
$50.00
Ipamorelin 10mg/vial is a lyophilized peptide product containing Ipamorelin as the active ingredient. Supplied by Hilma Biocare in a 1-vial pack, this product is listed as an injection/powder formulation and is available as US Stock.
Ipamorelin 10mg/vial – US Stock
Ipamorelin 10mg/vial from Hilma Biocare is a lyophilized peptide product containing Ipamorelin as its active ingredient. The product is supplied as an injection/powder formulation in a 1-vial pack and is listed under the peptide hormone subgroup.
Product Overview
Ipamorelin is described in the supplied product information as a pentapeptide and selective ghrelin/growth hormone secretagogue receptor agonist. The source identifies its amino acid sequence as Aib-His-D-2-Nal-D-Phe-Lys-NH2 and describes it as being derived from GHRP-1.
The supplied specifications identify the product strength as 10 mg per vial, with Ipamorelin listed as the active compound. The stated active half-life is 7–30 minutes.
Key Product Characteristics
- Active Ingredient: Ipamorelin
- Strength: 10 mg/vial
- Form: Injection/powder
- Product Type: Peptide hormone
- Pack Size: 1 vial
- Active Half-Life: 7–30 minutes
- Manufacturer/Brand: Hilma Biocare
- US Availability: US Stock
- Water Retention: Listed as No
- Aromatization: Listed as No
Product Specifications
| Specification | Details |
|---|---|
| Brand | Hilma Biocare |
| Active Ingredient | Ipamorelin |
| Strength | 10 mg/vial |
| Form | Injection/powder |
| Product Type | Peptide hormone |
| Pack Size | 1 vial |
| Active Half-Life | 7–30 minutes |
| Water Retention | No, according to supplied specifications |
| Aromatization | No, according to supplied specifications |
Product Characteristics
The supplied description characterizes Ipamorelin as a selective growth hormone secretagogue. It states that Ipamorelin acts by stimulating endogenous growth hormone production rather than replacing growth hormone directly.
The source also describes Ipamorelin as having a selective profile compared with pralmorelin (GHRP-2) and GHRP-6, noting that the compound is described as not affecting prolactin, follicle-stimulating hormone, luteinizing hormone, or thyroid-stimulating hormone levels. The supplied material further describes differences in its effects on adrenocorticotropic hormone and cortisol secretion.
These statements reflect the characteristics presented in the supplied product information and should not be interpreted as personalized medical advice or as a clinical recommendation.
About Hilma Biocare USA
Ipamorelin 10mg/vial is part of the Hilma Biocare product range. This product is supplied in a 1-vial format with 10 mg of Ipamorelin identified as the active ingredient and is listed as US Stock.
Important Information
Ipamorelin is a medically relevant peptide compound. The information provided here is intended to describe the product and its supplied specifications, not to provide individualized medical advice, dosing recommendations, treatment protocols, or instructions for self-administration.
The supplied source contains administration, dosage, application, contraindication, and side-effect information; these details are not reproduced as actionable instructions here. Individuals considering any medically relevant peptide product should consult an appropriately qualified healthcare professional regarding suitability, potential risks, and applicable use.
Reviews
There are no reviews yet.